Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ITOS |
---|---|---|
09:32 ET | 3750 | 18.04 |
09:34 ET | 100 | 18.09 |
09:36 ET | 100 | 18.11 |
09:38 ET | 100 | 18.13 |
09:39 ET | 200 | 18.145 |
09:41 ET | 100 | 18.12 |
09:43 ET | 405 | 18.155 |
09:45 ET | 1900 | 18.3 |
09:50 ET | 902 | 18.13 |
09:52 ET | 185 | 18.1096 |
09:54 ET | 1049 | 18.05 |
09:56 ET | 5326 | 17.82 |
09:57 ET | 1109 | 17.9 |
09:59 ET | 200 | 17.81 |
10:03 ET | 100 | 17.88 |
10:06 ET | 1974 | 17.945 |
10:08 ET | 700 | 18.0099 |
10:10 ET | 100 | 17.96 |
10:12 ET | 100 | 17.95 |
10:14 ET | 1300 | 17.86 |
10:17 ET | 200 | 17.9 |
10:19 ET | 400 | 17.94 |
10:21 ET | 600 | 17.975 |
10:28 ET | 1506 | 17.995 |
10:35 ET | 1619 | 17.94 |
10:42 ET | 500 | 18 |
10:51 ET | 100 | 17.99 |
10:53 ET | 200 | 17.97 |
10:57 ET | 1435 | 17.93 |
11:00 ET | 671 | 17.88 |
11:02 ET | 100 | 17.855 |
11:04 ET | 100 | 17.82 |
11:06 ET | 100 | 17.83 |
11:13 ET | 3422 | 17.8 |
11:15 ET | 534 | 17.77 |
11:18 ET | 11440 | 17.745 |
11:20 ET | 100 | 17.74 |
11:22 ET | 3930 | 17.76 |
11:24 ET | 600 | 17.8 |
11:26 ET | 300 | 17.875 |
11:27 ET | 958 | 17.89 |
11:29 ET | 1516 | 17.885 |
11:31 ET | 1203 | 17.85 |
11:33 ET | 100 | 17.85 |
11:36 ET | 341 | 17.849 |
11:38 ET | 2867 | 17.8454 |
11:40 ET | 1245 | 17.845 |
11:42 ET | 1400 | 17.88 |
11:44 ET | 900 | 17.87 |
11:45 ET | 1700 | 17.99 |
11:47 ET | 100 | 18.04 |
11:54 ET | 100 | 18.15 |
11:56 ET | 300 | 18.135 |
11:58 ET | 700 | 18.135 |
12:00 ET | 1165 | 18.1 |
12:03 ET | 2973 | 18.16 |
12:07 ET | 100 | 18.21 |
12:09 ET | 400 | 18.24 |
12:16 ET | 100 | 18.245 |
12:20 ET | 1058 | 18.16 |
12:23 ET | 100 | 18.17 |
12:30 ET | 1154 | 18.25 |
12:34 ET | 800 | 18.33 |
12:36 ET | 1616 | 18.3322 |
12:38 ET | 800 | 18.395 |
12:39 ET | 855 | 18.35 |
12:41 ET | 1168 | 18.34 |
12:43 ET | 1300 | 18.355 |
12:45 ET | 2300 | 18.4 |
12:48 ET | 3600 | 18.48 |
12:50 ET | 2654 | 18.4925 |
12:56 ET | 5084 | 18.54 |
12:57 ET | 770 | 18.53 |
12:59 ET | 1389 | 18.48 |
01:01 ET | 403 | 18.46 |
01:03 ET | 200 | 18.47 |
01:08 ET | 100 | 18.47 |
01:10 ET | 400 | 18.55 |
01:14 ET | 100 | 18.5388 |
01:15 ET | 100 | 18.555 |
01:17 ET | 100 | 18.555 |
01:19 ET | 2335 | 18.625 |
01:21 ET | 2444 | 18.665 |
01:24 ET | 1456 | 18.685 |
01:26 ET | 2123 | 18.61 |
01:30 ET | 500 | 18.515 |
01:32 ET | 291 | 18.5 |
01:35 ET | 500 | 18.4601 |
01:39 ET | 3700 | 18.415 |
01:42 ET | 100 | 18.415 |
01:46 ET | 549 | 18.43 |
01:48 ET | 1707 | 18.415 |
01:50 ET | 400 | 18.4 |
01:51 ET | 2245 | 18.38 |
01:57 ET | 500 | 18.3865 |
02:00 ET | 5239 | 18.34 |
02:02 ET | 900 | 18.32 |
02:04 ET | 200 | 18.33 |
02:06 ET | 100 | 18.3 |
02:09 ET | 100 | 18.3 |
02:13 ET | 300 | 18.295 |
02:15 ET | 300 | 18.3 |
02:18 ET | 100 | 18.3 |
02:20 ET | 1301 | 18.29 |
02:22 ET | 300 | 18.26 |
02:26 ET | 1442 | 18.29 |
02:27 ET | 100 | 18.3 |
02:29 ET | 100 | 18.325 |
02:36 ET | 1855 | 18.315 |
02:42 ET | 2294 | 18.29 |
02:44 ET | 2119 | 18.32 |
02:45 ET | 200 | 18.3523 |
02:49 ET | 100 | 18.33 |
02:51 ET | 100 | 18.335 |
02:54 ET | 610 | 18.34 |
02:56 ET | 1782 | 18.33 |
03:00 ET | 1442 | 18.285 |
03:02 ET | 180 | 18.3 |
03:03 ET | 700 | 18.32 |
03:07 ET | 400 | 18.345 |
03:09 ET | 1288 | 18.335 |
03:12 ET | 500 | 18.35 |
03:16 ET | 400 | 18.4 |
03:18 ET | 400 | 18.37 |
03:20 ET | 1250 | 18.36 |
03:23 ET | 600 | 18.34 |
03:25 ET | 100 | 18.35 |
03:27 ET | 7939 | 18.34 |
03:30 ET | 700 | 18.32 |
03:32 ET | 974 | 18.25 |
03:34 ET | 200 | 18.28 |
03:36 ET | 399 | 18.27 |
03:38 ET | 356 | 18.2614 |
03:39 ET | 1231 | 18.23 |
03:41 ET | 500 | 18.21 |
03:43 ET | 100 | 18.205 |
03:45 ET | 992 | 18.19 |
03:48 ET | 1697 | 18.18 |
03:50 ET | 200 | 18.18 |
03:52 ET | 1537 | 18.22 |
03:54 ET | 1964 | 18.235 |
03:56 ET | 4200 | 18.12 |
03:57 ET | 2200 | 18.07 |
03:59 ET | 51969 | 18.09 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Iteos Therapeutics Inc | 653.5M | -4.8x | --- |
AnaptysBio Inc | 683.2M | -4.1x | --- |
Arrivent Biopharma Inc | 655.8M | 0.0x | --- |
Lexicon Pharmaceuticals Inc | 639.8M | -2.1x | --- |
Phathom Pharmaceuticals Inc | 637.4M | -2.5x | --- |
Taysha Gene Therapies Inc | 577.9M | -2.6x | --- |
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes three clinical-stage programs targeting novel, validated immuno-oncology pathways. Its lead antibody product candidate, belrestotug, also known as EOS-448/GSK4428859A, is an antagonist of TIGIT, an immune checkpoint with multiple mechanisms of action. Its advanced program is inupadenant, also known as EOS-850, a next-generation adenosine 2A receptor (A2AR) antagonist tailored to overcome the specific adenosine-mediated immunosuppression found in the tumor microenvironment. Its program to initiate clinical trials is EOS-984, a potentially first-in-class small molecule focused on a new mechanism in the adenosine pathway by targeting equilibrative nucleoside transporter 1 (ENT1), a dominant transporter of adenosine on lymphocytes involved in T cell metabolism.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $653.5M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 36.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.50 |
EPS | $-3.78 |
Book Value | $16.05 |
P/E Ratio | -4.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.